Takiguchi M - Search Results

1

Different rates of HLA class I molecule assembly which are determined by amino acid sequence in the alpha 2 domain.

Hill A, Takiguchi M, McMichael A. Hill A, et al. Among authors: takiguchi m. Immunogenetics. 1993;37(2):95-101. doi: 10.1007/BF00216831. Immunogenetics. 1993. PMID: 7678580

2

Molecular analysis of the association of HLA-B53 and resistance to severe malaria.

Hill AV, Elvin J, Willis AC, Aidoo M, Allsopp CE, Gotch FM, Gao XM, Takiguchi M, Greenwood BM, Townsend AR, et al. Hill AV, et al. Among authors: takiguchi m. Nature. 1992 Dec 3;360(6403):434-9. doi: 10.1038/360434a0. Nature. 1992. PMID: 1280333

3

An HLA-B35-restricted epitope modified at an anchor residue results in an antagonist peptide.

Dong T, Boyd D, Rosenberg W, Alp N, Takiguchi M, McMichael A, Rowland-Jones S. Dong T, et al. Among authors: takiguchi m. Eur J Immunol. 1996 Feb;26(2):335-9. doi: 10.1002/eji.1830260210. Eur J Immunol. 1996. PMID: 8617300

4

Novel HIV-1 clade B candidate vaccines designed for HLA-B*5101(+) patients protected mice against chimaeric ecotropic HIV-1 challenge.

Roshorm Y, Hong JP, Kobayashi N, McMichael AJ, Volsky DJ, Potash MJ, Takiguchi M, Hanke T. Roshorm Y, et al. Among authors: takiguchi m. Eur J Immunol. 2009 Jul;39(7):1831-40. doi: 10.1002/eji.200939309. Eur J Immunol. 2009. PMID: 19585509 Free article.

5

Expansion of HIV-1-specific CD28- CD45RA- CD8+ T cells in chronically HIV-1-infected individuals.

Tomiyama H, Oka S, Ogg GS, Ida S, McMichael AJ, Takiguchi M. Tomiyama H, et al. Among authors: takiguchi m. AIDS. 2000 Sep 8;14(13):2049-51. doi: 10.1097/00002030-200009080-00023. AIDS. 2000. PMID: 10997412 No abstract available.

6

Identification of novel HIV-1-derived HLA-E-binding peptides.

Hannoun Z, Lin Z, Brackenridge S, Kuse N, Akahoshi T, Borthwick N, McMichael A, Murakoshi H, Takiguchi M, Hanke T. Hannoun Z, et al. Among authors: takiguchi m. Immunol Lett. 2018 Oct;202:65-72. doi: 10.1016/j.imlet.2018.08.005. Epub 2018 Aug 30. Immunol Lett. 2018. PMID: 30172717 Free PMC article.

7

The structure of HLA-B35 suggests that it is derived from HLA-Bw58 by two genetic mechanisms.

Ooba T, Hayashi H, Karaki S, Tanabe M, Kano K, Takiguchi M. Ooba T, et al. Among authors: takiguchi m. Immunogenetics. 1989;30(2):76-80. doi: 10.1007/BF02421534. Immunogenetics. 1989. PMID: 2788131

8

Isolation of a human allo-peptide presented by HLA-B51 molecules.

Tomiyama H, Takamiya Y, Hill AB, Cerundolo V, Kelly A, Egawa K, Trowsdale J, Takiguchi M. Tomiyama H, et al. Among authors: takiguchi m. Int Immunol. 1995 Jun;7(6):905-9. doi: 10.1093/intimm/7.6.905. Int Immunol. 1995. PMID: 7577798

9

Molecular analysis of HLA-B39 subtypes.

Kato N, Karaki S, Kashiwase K, Müller C, Akaza T, Juji T, Kano K, Takiguchi M. Kato N, et al. Among authors: takiguchi m. Immunogenetics. 1993;37(3):212-6. doi: 10.1007/BF00191887. Immunogenetics. 1993. PMID: 8420828

10

Serological demonstration of HLA-Bw4/Bw6 epitopes on hybrid molecules between HLA-B35 and HLA-B51.

Sekimata M, Hayashi H, Nakayama S, Kano K, Takiguchi M. Sekimata M, et al. Among authors: takiguchi m. Immunogenetics. 1989;30(3):229-31. doi: 10.1007/BF02421213. Immunogenetics. 1989. PMID: 2476390 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

859 results

Search Page

Filters